ICPMS
Menu
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike
Language Čeština

    1. Databases

    1. Industries

    1. Instrumentation

    1. Manufacturer

    1. Author

    1. Content Type

    1. Publication Date

    Applications from the field of Pharma & Biopharma | LabRulez ICPMS

    Validation of Analysis Method Using ICPMS-2030 Based on USP <233> ELEMENTAL IMPURITIES - PROCEDURES

    Applications
    | 2020 | Shimadzu
    ICP/MS
    Instrumentation
    ICP/MS
    Manufacturer
    Shimadzu
    Industries
    Pharma & Biopharma

    Validating performance of an Agilent ICP‑MS for USP <232>/<233> & ICH Q3D(R2)/Q2(R1)

    Applications
    | 2022 | Agilent Technologies
    ICP/MS
    Instrumentation
    ICP/MS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Analysis of Elemental Impurities in Synthetic Oligonucleotides by ICP-MS

    Applications
    | 2023 | Agilent Technologies
    ICP/MS
    Instrumentation
    ICP/MS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Rapid Identification of Raw Materials Inside Packaging

    Applications
    | 2021 | Agilent Technologies
    RAMAN Spectroscopy
    Instrumentation
    RAMAN Spectroscopy
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma
    • Prev
    • 1
    • Next
     

    Related content

    ‌

    Advances in Chromatography and Electrophoresis & Chiranal 2024 (Programme)

    Mo, 13.5.2024
    Advances in Chromatography and Electrophoresis & Chiranal
    ‌

    Josef Michl, world-renowned Czech chemist, passes away

    Mo, 13.5.2024
    Ústav organické chemie a biochemie AV ČR
    ‌

    Mother’s protein intake during pregnancy can affect newborn’s facial development

    Su, 12.5.2024
    CEITEC
    ‌
    Other projects
    Follow us
    More information
    WebinarsAbout usContact usTerms of use
    LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike